Benitec Wins US Patent Allowance, Says Separate IP Re-exam Likely to Extend into Late 2010

The allowed patent covers the use of multiple-promoter expression cassettes for simultaneous delivery of RNAi. Separately, the Aussie shop said the USPTO won’t likely decide a company appeal until the third quarter of next year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.